Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1980 2
1983 1
1987 2
1988 4
1989 4
1990 2
1991 2
1992 6
1993 3
1994 4
1995 6
1996 2
1997 7
1998 9
1999 9
2000 14
2001 10
2002 7
2003 5
2004 11
2005 12
2006 7
2007 10
2008 9
2009 17
2010 19
2011 15
2012 13
2013 14
2014 30
2015 28
2016 55
2017 58
2018 68
2019 77
2020 100
2021 113
2022 139
2023 125
2024 161
2025 95

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,156 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial.
Brody JD, Jørgensen J, Belada D, Costello R, Trněný M, Vitolo U, Lewis DJ, Karimi YH, Sureda A, André M, Wahlin BE, Lugtenburg PJ, Jiang T, Karagoz K, Steele AJ, Abbas A, Wang L, Risum M, Cordoba R. Brody JD, et al. Blood. 2025 Apr 10;145(15):1621-1631. doi: 10.1182/blood.2024026830. Blood. 2025. PMID: 39792928 Free PMC article. Clinical Trial.
Epcoritamab, a CD3CD20 bispecific antibody approved for R/R DLBCL after 2 therapy lines, has shown promising safety and efficacy in various combinations. ...Epcoritamab plus GemOx yielded deep, durable responses and favorable long-term outcomes in ASCT-ineligible …
Epcoritamab, a CD3CD20 bispecific antibody approved for R/R DLBCL after 2 therapy lines, has shown promising safety and effica …
Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016.
Srivastava AK, Wang Y, Huang R, Skinner C, Thompson T, Pollard L, Wood T, Luo F, Stevenson R, Polimanti R, Gelernter J, Lin X, Lim IY, Wu Y, Teh AL, Chen L, Aris IM, Soh SE, Tint MT, MacIsaac JL, Yap F, Kwek K, Saw SM, Kobor MS, Meaney MJ, Godfrey KM, Chong YS, Holbrook JD, Lee YS, Gluckman PD, Karnani N; GUSTO study group; Kapoor A, Lee D, Chakravarti A, Maercker C, Graf F, Boutros M, Stamoulis G, Santoni F, Makrythanasis P, Letourneau A, Guipponi M, Panousis N, Garieri M, Ribaux P, Falconnet E, Borel C, Antonarakis SE, Kumar S, Curran J, Blangero J, Chatterjee S, Kapoor A, Akiyama J, Auer D, Berrios C, Pennacchio L, Chakravarti A, Donti TR, Cappuccio G, Miller M, Atwal P, Kennedy A, Cardon A, Bacino C, Emrick L, Hertecant J, Baumer F, Porter B, Bainbridge M, Bonnen P, Graham B, Sutton R, Sun Q, Elsea S, Hu Z, Wang P, Zhu Y, Zhao J, Xiong M, Bennett DA, Hidalgo-Miranda A, Romero-Cordoba S, Rodriguez-Cuevas S, Rebollar-Vega R, Tagliabue E, Iorio M, D’Ippolito E, Baroni S, Kaczkowski B, Tanaka Y, Kawaji H, Sandelin A, Andersson R, Itoh M, Lassmann T; The FANTOM5 Consortium; Hayashizaki Y, Carninci P, Forrest ARR, Semple CA, Rosenthal EA, Shirts B, Amendola L, Gallego C, Horike-Pyne… See abstract for full author list ➔ Srivastava AK, et al. Hum Genomics. 2016 May 26;10 Suppl 1(Suppl 1):12. doi: 10.1186/s40246-016-0063-5. Hum Genomics. 2016. PMID: 27294413 Free PMC article.
Jimenez-Morales, M. Ramirez, J. Nunez, V. Bekker, Y. Leal, E. Jimenez, A. Medina, A. Hidalgo, J. ...M. Cutiongco De La Paz, R. Sy, J. Nevado, P. Reganit, L. Santos, J. D. Magno, F. E. Punzalan , D. Ona , E. Llanes, R. ...
Jimenez-Morales, M. Ramirez, J. Nunez, V. Bekker, Y. Leal, E. Jimenez, A. Medina, A. Hidalgo, J. ...M. Cutiongco
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C. Fishbein L, et al. Pancreas. 2021 Apr 1;50(4):469-493. doi: 10.1097/MPA.0000000000001792. Pancreas. 2021. PMID: 33939658
Impact of Next Generation Sequencing in Unraveling the Genetics of 1036 Spanish Families With Inherited Macular Dystrophies.
Del Pozo-Valero M, Riveiro-Alvarez R, Martin-Merida I, Blanco-Kelly F, Swafiri S, Lorda-Sanchez I, Trujillo-Tiebas MJ, Carreño E, Jimenez-Rolando B, Garcia-Sandoval B, Corton M, Avila-Fernandez A, Ayuso C. Del Pozo-Valero M, et al. Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):11. doi: 10.1167/iovs.63.2.11. Invest Ophthalmol Vis Sci. 2022. PMID: 35119454 Free PMC article.
Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm.
Oller J, Gabandé-Rodríguez E, Ruiz-Rodríguez MJ, Desdín-Micó G, Aranda JF, Rodrigues-Diez R, Ballesteros-Martínez C, Blanco EM, Roldan-Montero R, Acuña P, Forteza Gil A, Martín-López CE, Nistal JF, Lino Cardenas CL, Lindsay ME, Martín-Ventura JL, Briones AM, Redondo JM, Mittelbrunn M. Oller J, et al. Circulation. 2021 May 25;143(21):2091-2109. doi: 10.1161/CIRCULATIONAHA.120.051171. Epub 2021 Mar 12. Circulation. 2021. PMID: 33709773 Free PMC article.
OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On.
Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, Collado P, Filippou G, Schmidt WA, Jousse-Joulin S, Mandl P, Conaghan PG, Wakefield RJ, Keen HI, Terslev L, D'Agostino MA; OMERACT Ultrasound Working Group. Bruyn GA, et al. J Rheumatol. 2019 Oct;46(10):1388-1393. doi: 10.3899/jrheum.181095. Epub 2019 Feb 1. J Rheumatol. 2019. PMID: 30709946 Free article.
Vaginal and rectal microbiome contribute to genital inflammation in chronic pelvic pain.
Jimenez N, Norton T, Diadala G, Bell E, Valenti M, Farland LV, Mahnert N, Herbst-Kralovetz MM. Jimenez N, et al. BMC Med. 2024 Jul 8;22(1):283. doi: 10.1186/s12916-024-03500-1. BMC Med. 2024. PMID: 38972981 Free PMC article.
Statistical analysis was conducted with SAS, R, MicrobiomeAnalyst, MetaboAnalyst, and QIIME 2. RESULTS: Significant differences were observed between participants with CPP alone, CPP-Endo, and surgical controls for body mass index, ethnicity, diagnosis of ovarian cysts, an …
Statistical analysis was conducted with SAS, R, MicrobiomeAnalyst, MetaboAnalyst, and QIIME 2. RESULTS: Significant differences were …
Salt Intake and Immunity.
Afsar B, Kuwabara M, Ortiz A, Yerlikaya A, Siriopol D, Covic A, Rodriguez-Iturbe B, Johnson RJ, Kanbay M. Afsar B, et al. Hypertension. 2018 Jul;72(1):19-23. doi: 10.1161/HYPERTENSIONAHA.118.11128. Epub 2018 May 14. Hypertension. 2018. PMID: 29760151 Review. No abstract available.
A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4.
Singh D, Guller P, Reid F, Doffman S, Seppälä U, Psallidas I, Moate R, Smith R, Kiraga J, Jimenez E, Brooks D, Kelly A, Nordenmark LH, Waqas Sadiq M, Mateos Caballero L, Kell C, Belvisi MG, Pandya H. Singh D, et al. Eur Respir J. 2025 Apr 3:2402231. doi: 10.1183/13993003.02231-2024. Online ahead of print. Eur Respir J. 2025. PMID: 40154559 Free article.
Do You See Patients?
Jimenez RR. Jimenez RR. J Christ Nurs. 2019 Jan/Mar;36(1):61. doi: 10.1097/CNJ.0000000000000560. J Christ Nurs. 2019. PMID: 30531516 No abstract available.
1,156 results